In 2017, thousands of people skirmished in fights between pro-Trump groups and counterprotesters at a rally in Portland, following a stabbing on public transit train after a man reportedly harassed a woman wearing a hijab.
In Beijing, based on ticket-booking records, it is estimated that passenger trips made by rail and air will each decline by 70 percent in the near future, according to Rong Jun, deputy director of the Beijing Municipal Transport Commission.
In 2017, Huawei invested 89.7 billion yuan (.3 billion) into research and development, accounting for 15 percent of its total revenue. It's ranked sixth in terms of global R&D investment.
In 2018, Tibet received a record number of 33.68 million tourists, up by 31.5 percent year-on-year, according to the region's latest government report.
In 2019, SAIC delivered 350,000 vehicles overseas, up 26 percent year-on-year, accounting for more than one third of Chinese carmakers' total. It plans to add another two to three models to the lineup available in Europe and further expand in the Singaporean market this year.
In August, with evidence from Alibaba, police in Loudi, Hunan province, broke up a ring producing and selling counterfeit weight-loss drugs, with a sales network in more than 20 provinces. Total trade by the ring exceeded 100 million yuan (.15 million).
重庆seo排名公司
In 2017, China's intellectual property royalties earned abroad surpassed billion, according to SIPO.
In 2017, Moutai, a distiller from Maotai town in Guizhou province, achieved revenue of 76.4 billion yuan, up 50.5 percent from 2016. This year, it aims to net revenue of 90 billion yuan, adding 18 percent or more, and it plans to produce and sell over 120,000 metric tons of white spirits, according to the company.
In August, New York joined Vermont and Connecticut in a lawsuit aimed at halting Trump's attempt to reject immigrants likely to become a "public charge" - relying on programs such as food stamps, Medicaid and housing assistance, rather than supporting themselves.
In April 2017, science journal publisher Springer retracted 107 papers from its journal Tumor Biology after evidence emerged that their authors, mostly Chinese, had faked peer reviews that helped get the papers accepted.